Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress

Molecular Cancer

Volumn 3, Issue , 2004, Pages

  Marjon, Philip L ^a   Bobrovnikova Marjon, Ekaterina V ^a   Abcouwer, Steve F ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Breast cancer; Brefeldin A; Glucose; Glucose regulated protein 78 (GRP78); Glutamine; Growth arrest and DNA damage inducible gene 153 (GADD153); Hypoxia; Ionomycin; Thapsigargin; Tunicamycin

Indexed keywords

AMINO ACID; ANGIOGENIC FACTOR; COBALT CHLORIDE; CYTOKINE; GLUCOSE; GLUCOSE REGULATED PROTEIN 78; GLUTAMINE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INTERLEUKIN 8; MESSENGER RNA; TUNICAMYCIN; VASCULOTROPIN; CCAAT ENHANCER BINDING PROTEIN; COBALT; DDIT3 PROTEIN, HUMAN; DNA; GLUCOSE REGULATED PROTEIN 78, PROTOZOAN; HEAT SHOCK PROTEIN; RNA; TRANSCRIPTION FACTOR;

AMINO ACID DEFICIENCY; ANGIOGENESIS; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CULTURE TECHNIQUE; ENDOPLASMIC RETICULUM; GENE ACTIVATION; GENE EXPRESSION; GENE SWITCHING; HUMAN; HUMAN CELL; HYPOTHESIS; HYPOXIA; MICROENVIRONMENT; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; SOLID TUMOR; TUMOR VASCULARIZATION; UPREGULATION; ADENOCARCINOMA; BIOSYNTHESIS; BREAST TUMOR; CELL HYPOXIA; DNA DAMAGE; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; SECRETION (PROCESS); TUMOR CELL CULTURE;

ADENOCARCINOMA; AMINO ACIDS; BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEINS; CELL HYPOXIA; COBALT; DNA DAMAGE; DNA, NEOPLASM; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLUTAMINE; HEAT-SHOCK PROTEINS; HUMANS; INTERLEUKIN-8; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUNICAMYCIN; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 2942557118     PISSN: 14764598     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-4598-3-4     Document Type: Article

References (58)

1. Vaupel P, Hockel M: Blood supply, oxygenation status and metabolic micromilieu of breast cancers: characterization and therapeutic relevance. International Journal of Oncology. 2000, 17:869-879.
2. Giordano FJ, Johnson RS: Angiogenesis: the role of the microenvironment in flipping the switch. Current Opinion in Genetics & Development. 2001, 11:35-40.
3. Marti HH, Risau W: Angiogenesis in ischemic disease. Thrombosis & Haemostasis 1999, 82:44-52.
4. Harris AL: Hypoxia - a key regulatory factor in tumour growth. Nature Reviews. Cancer. 2002, 2:38-47.
5. Ferrara N: Role of vascular endothelial growth factor in regulation of physiological angiogenesis. American Journal of Physiology - Cell Physiology 2001, 280:C1358-66.
6. Ferrara N: Molecular and biological properties of vascular endothelial growth factor. Journal of Molecular Medicine 1999, 77:527-543.
7. Baek JH, Jang JE, Kang CM, Chung HY, Kim ND, Kim KW: Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 2000, 19:4621-4631.
8. Pidgeon GP, Barr MP, Harmey JH, Foley DA, Bouchier-Hayes DJ: Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. British Journal of Cancer 2001, 85:273-278.
9. Foekens JA, Peters HA, Grebenchtchikov N, Look MP, Meijer-Van Gelder ME, Geurts-Moespot A, van Der Kwast TH, Sweep CG, Klijn JG: High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Cancer Research 2001, 61:5407-5414.
10. Gasparini G: Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 2000, 5:37-44.
11. Kotch LE, Iyer NV, Laughner E, Semenza GL: Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Developmental Biology 1999, 209:254-267.
12. Tsuzuki Y, Fukumura D, Oosthuyse B, Koike C, Carmeliet P, Jain RK: Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Research 2000, 60:6248-6252.
13. Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, Ratcliffe PJ: Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:8104-8109.
14. Raleigh JA, Calkins-Adams DP, Rinker LH, Ballenger CA, Weissler MC, Fowler W. C., Jr., Novotny DB, Varia MA: Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Research 1998, 58:3765-3768.
15. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK, Seed B: Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998, 94:715-725.
16. West CM, Cooper RA, Loncaster JA, Wilks DP, Bromley M: Tumor vascularity: a histological measure of angiogenesis and hypoxia. Cancer Research 2001, 61:2907-2910.
17. Park SH, Kim KW, Lee YS, Baek JH, Kim MS, Lee YM, Lee MS, Kim YJ: Hypoglycemia-induced VEGF expression is mediated by intracellular Ca2+ and protein kinase C signaling pathway in HepG2 human hepatoblastoma cells. International Journal of Molecular Medicine 2001, 7:91-96.
18. Satake S, Kuzuya M, Miura H, Asai T, Ramos MA, Muraguchi M, Ohmoto Y, Iguchi A: Up-regulation of vascular endothelial growth factor in response to glucose deprivation. Biology of the Cell 1998, 90:161-168.
19. Stein I, Neeman M, Shweiki D, Itin A, Keshet E: Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Molecular & Cellular Biology 1995, 15:5363-5368.
20. Abcouwer SF, Marjon PL, Loper RK, Vander Jagt DL: Response of VEGF expression to amino acid deprivation and inducers of endoplasmic reticulum stress. Investigative Ophthalmology & Visual Science. 2002, 43:2791-2798.
21. Gazit G, Kane SE, Nichols P, Lee AS: Use of the stress-inducible grp78/BiP promoter in targeting high level gene expression in fibrosarcoma in vivo. Cancer Research 1995, 55:1660-1663.
22. Gazit G, Hung G, Chen X, Anderson WF, Lee AS: Use of the glucose starvation-inducible glucose-regulated protein 78 promoter in suicide gene therapy of murine fibrosarcoma. Cancer Research 1999, 59:3100-3106.
23. Reddy RK, Lu J, Lee AS: The endoplasmic reticulum chaperone glycoprotein GRP94 with Ca(2+)-binding and antiapoptotic properties is a novel proteolytic target of calpain during etoposide-induced apoptosis. Journal of Biological Chemistry. 1999, 274:28476-28483.
24. Fernandez PM, Tabbara SO, Jacobs LK, Manning FC, Tsangaris TN, Schwartz AM, Kennedy KA, Patierno SR: Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions. Breast Cancer Research & Treatment 2000, 59:15-26.
25. Chen X, Ding Y, Liu CG, Mikhail S, Yang CS: Overexpression of glucose-regulated protein 94 (Grp94) in esophageal adenocarcinomas of a rat surgical model and humans. Carcinogenesis 2002, 23:123-130.
26. Korabiowska M, Cordon-Cardo C, Betke H, Schlott T, Kotthaus M, Stachura J, Brinck U: GADD153 is an independent prognostic factor in melanoma: immunohistochemical and molecular genetic analysis. Histology & Histopathology 2002, 17:805-811.
27. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proceedings of the National Assembly of Science USA 1987, 84:9233-9237.
28. Xie K: Interleukin-8 and human cancer biology. Cytokine & Growth Factor Reviews 2001, 12:375-391.
29. De Larco JE, Wuertz BR, Rosner KA, Erickson SA, Gamache DE, Manivel JC, Furcht LT: A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. American Journal of Pathology 2001, 158:639-646.
30. Li A, Dubey S, Varney ML, Dave BJ, Singh RK: IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. Journal of Immunology. 2003, 170:3369-3376.
31. Huang S, Mills L, Mian B, Tellez C, McCarty M, Yang XD, Gudas JM, Bar-Eli M: Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. American Journal of Pathology. 2002, 161:125-134.
32. Masuya D, Huang C, Liu D, Kameyama K, Hayashi E, Yamauchi A, Kobayashi S, Haba R, Yokomise H: The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients. Cancer 2001, 92:2628-2638.
33. Kim SJ, Uehara H, Karashima T, McCarty M, Shih N, Fidler IJ: Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia (New York) 2001, 3:33-42.
34. Rofstad EK, Halsor EF: Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Research 2000, 60:4932-4938.
35. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP: Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clinical Cancer Research 2000, 6:2104-2119.
36. Fujimoto J, Sakaguchi H, Aoki I, Tamaya T: Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Research. 2000, 60:2632-2635.
37. Nurnberg W, Tobias D, Otto F, Henz BM, Schadendorf D: Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma.[comment]. Journal of Pathology. 1999, 189:546-551.
38. Retzlaff S, Padro T, Koch P, Oelmann E, Lugering N, Mesters RM, Berdel WE: Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma. Oncology Reports. 2002, 9:525-527.
39. Orditura M, De Vita F, Catalano G, Infusino S, Lieto E, Martinelli E, Morgillo F, Castellano P, Pignatelli C, Galizia G: Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: relationship with prognosis. Journal of Interferon & Cytokine Research. 2002, 22:1129-1135.
40. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M: Multiple control of interleukin-8 gene expression. Journal of Leukocyte Biology. 2002, 72:847-855.
41. Takaya H, Andoh A, Shimada M, Hata K, Fujiyama Y, Bamba T: The expression of chemokine genes correlates with nuclear factor-kappaB activation in human pancreatic cancer cell lines. Pancreas 2000, 21:32-40.
42. Huang S, DeGuzman A, Bucana CD, Fidler IJ: Level of interleukin-8 expression by metastatic human melanoma cells directly correlates with constitutive NF-kappaB activity. Cytokines, Cellular & Molecular Therapy 2000, 6:9-17.
43. Pahl HL, Baeuerle PA: The ER-overload response: activation of NF-kappa B. Trends in Biochemical Sciences 1997, 22:63-67.
44. Yuan Y, Beitner-Johnson D, Millhorn DE: Hypoxia-inducible factor 2alpha binds to cobalt in vitro. Biochemical & Biophysical Research Communications 2001, 288:849-854.
45. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
46. Vukovic V, Haugland HK, Nicklee T, Morrison AJ, Hedley DW: Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Research. 2001, 61:7394-7398.
47. Richard DE, Berra E, Pouyssegur J: Angiogenesis: how a tumor adapts to hypoxia. Biochemical & Biophysical Research Communications 1999, 266:718-722.
48. Brown JM, Giaccia AJ: The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Research. 1998, 58:1408-1416.
49. Griffiths JR, McSheehy PM, Robinson SP, Troy H, Chung YL, Leek RD, Williams KJ, Stratford IJ, Harris AL, Stubbs M: Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): evidence of an anabolic role for the HIF-1 pathway. Cancer Research. 2002, 62:688-695.
50. Shi Q, Xiong Q, Le X, Xie K: Regulation of interleukin-8 expression by tumor-associated stress factors. Journal of Interferon & Cytokine Research 2001, 21:553-566.
51. Karashima T, Sweeney P, Kamat A, Huang S, Kim SJ, Bar-Eli M, McConkey DJ, Dinney CP: Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8. Clinical Cancer Research 2003, 9:2786-2797.
52. Jiang HY, Wek SA, McGrath BC, Scheuner D, Kaufman RJ, Cavener DR, Wek RC: Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. Molecular and cell Biology 2003, 23:5651-5663.
53. Shweiki D, Neeman M, Itin A, Keshet E: Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:768-772.
54. Collins CL, Wasa M, Souba WW, Abcouwer SF: Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell lines. Journal of Cell Physiology 1998, 176:166-178.
55. Collins CL, Wasa M, Souba WW, Abcouwer SF: Regulation of glutamine synthetase in human breast carcinoma cells and experimental tumors. Surgery 1997, 122:451-63; discussion 463-4.
56. Song MS, Park YK, Lee JH, Park K: Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade. Cancer Research 2001, 61:8322-8330.
57. Chomcynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
58. Abcouwer SF, Schwarz C, Meguid RA: Glutamine deprivation induces the expression of GADD45 and GADD153 primarily by mRNA stabilization. J. Biol. Chem. 1999, 274:28645-28651.